Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know. Avantor missed analysts’ revenue expectations by 0.7% last ...

The clinical services business is part of Avantor’s Laboratory Solutions segment and employs about 800 people. It is expected ...

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes ...

Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 2.1% year on year to $1.69 billion. Its non-GAAP profit of $0.27 per ...

Avantor has a 12 month low of $19.59 and a 12 month high of $28.00. The stock has a 50 day moving average of $21.71 and a 200-day moving average of $23.47. The company has a market capitalization ...

Michael Stubblefield, CEO, highlighted Avantor's return to growth in Q4 2024 with low single-digit organic growth and strong bioprocessing performance, achieving high single-digit organic growth ...

NEW YORK - Avantor, Inc. (NYSE:AVTR), a provider of mission-critical products and services to life sciences and advanced technology industries, reported fourth-quarter 2024 results on Friday that ...

PHILADELPHIA, PA — United States Attorney Jacqueline C. Romero announced that Avantor, Inc., based in Radnor, PA, has agreed ...

(RTTNews) - Avantor, Inc (AVTR) released a profit for its fourth quarter that increased from the same period last year and beat the Street estimates. The company's earnings totaled $500.4 million ...